Identification of interleukin 1-induced apoptosis in rat islets using in situ specific labelling of fragmented DNA

Journal of Autoimmunity

Volumn 9, Issue 3, 1996, Pages 309-313

  Dunger, Annemarie ^a   Augstein, Petra ^a   Schmidt, Siegfried ^a   Fischer, Uwe ^a  

^a Institut fur Diabetes 'Gerhardt Katsch'   (Germany)

Author keywords

Islets of Langerhans; Nicotinamide; Nitric oxide; Programmed cell death

Indexed keywords

DNA FRAGMENT; INTERLEUKIN 1BETA; NITRIC OXIDE;

ANIMAL CELL; APOPTOSIS; CONFERENCE PAPER; CONTROLLED STUDY; ETIOLOGY; INSULIN RELEASE; NONHUMAN; PANCREAS; PANCREAS ISLET; PRIORITY JOURNAL; RAT;

EID: 0030175704     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1996.0042     Document Type: Conference Paper

References (34)

1. 1. Dunger A., Schröder D., Augstein P., Witstruck T., Wachlin G., Vogt L., Ziegler B., Schmidt S. 1995. Impact of metabolic activity of beta cells on cytokine-induced damage and recovery of rat pancreatic islets. Acta Diabetol. 32: 217-224
2. 2. Mandrup-Poulsen T., Bendtzen K., Nerup J., Egeberg J., Nielsen J.H. 1986. Mechanisms of pancreatic islet-cell destruction: dose dependent cytotoxic effect of soluble blood mononuclear cell mediators on isolated islets of Langerhans. Allergy 41: 250-259
3. 3. Dunger A., Cunningham J.M., Delaney C.A., Lowe J.E., Green M.H.L., Bone A.J., Green I.C. 1996. Tumor necrosis factor-alpha and interferon-gamma inhibit insulin secretion and cause DNA damage in neonatal rat islets - extent of nitric oxide involvement. Diabetes 45: 183-189
4. 4. Cetkovic-Cvrlje M., Eizirik D. 1994. TNF-alpha and IFN-gamma potentiate the deleterious effects of IL 1-beta on mouse pancreatic islets mainly via generation of nitric oxide. Cytokine 6: 399-406
5. 5. Corbett J.A., McDaniel M.L. 1995. Intraislet release of interleukin 1 inhibits β cell function by inducing β cell expression of inducible nitric oxide synthase. J. Exp. Med. 181: 559-568
6. 6. Moncada S., Palmer R.M.J., Higgs E.A. 1991. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev. 43: 109-142
7. 7. Nathan C. 1992. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6: 3051-3064
8. 8. Kitajima I., Kawahara K., Nakajima T., Soejima Y., Matsuyama T., Maruyama I. 1994. Nitric oxide-mediated apoptosis in murine mastocytoma. Biochem. Biophys. Res. Commun. 204: 244-251
9. 9. Messmer U.K., Ankarcrona M., Nicotera P., Brüne B. 1994. p53 expression in nitric oxide-induced apoptosis. FEBS Lett. 355: 23-26
10. 10. Carson D.A., Ribeiro J.M. 1993. Apoptosis and disease. The Lancet 341: 1251-1254
11. 11. Arends M.J., Morris R.G., Wyllie A.H. 1990. Apoptosis: the role of the endonuclease. Am. J. Pathol. 136: 593-608
12. 12. Kressel M., Groscurth P. 1994. Distinction of apoptotic and necrotic cell death by in situ labelling of fragmented DNA. Cell Tissue Res. 278: 549-556
13. 13. Gold R., Schmied M., Giegerich G., Breitschopf H., Hartung H.P., Toyka K.V., Lassmann H. 1994. Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques. Laboratory Invest. 71: 219-225
14. 14. Klöting I., Vogt L., Reetz I.C., Wurst W., Hedrich H.J., Guenther E. 1990. New congeneic rat strains for the separate study of MHC and non-MHC genetic effects in the development of diabetes in BB rats. Diabetes Res. 15: 41-45
15. 15. Hehmke B., Kohnert K.D., Odselius R. 1986. The use of a new dextran gradient medium for rapid isolation of functionally intact neonatal rat pancreatic islets. Diabetes Res. 3: 13-16
16. 16. Green L., Wagner D., Glogowski J., Skipper P.L., Wishnok J.S., Tannenbaum S.R. 1982. Analysis of nitrate, nitrite and [15N] nitrate in biological fluids. Anal. Biochem. 126: 131-138
17. 17. Gey G.O., Gey M.H. 1936. Maintenance of human normal cells and tumour cells in continuous culture. Am. J. Cancer 27: 45-76
18. 18. Besch W., Woltanski K.P., Keilacker H., Diaz-Alonzso J.M., Schulz B., Amendt P., Kohnert K.D., Ziegler M. 1987. Measurement of insulin in human sera using a new RIA kit. 1. Insulin determination in the absence of insulin antibodies - conventional assay and micromodification. Exp. Clin. Endocrinol. 90: 264-270
19. 19. Coates P.J. 1994. Molecular methods for the identification of apoptosis in tissues. J. Histotechnol. 17: 261-267
20. 20. Sambrook J., Fritsch E.F., Maniatis T. 1989. Enzymes used in molecular cloning. In Molecular Cloning. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. pp. 5.33-5.56
21. 21. Southern C., Schulster D., Green I.C. 1990. Inhibition of insulin secretion by interleukin-1β and tumor necrosis factor-α via an L-arginine-dependent nitric oxide generating mechanism. FEBS Lett. 276: 42-44
22. 22. Corbett J.A., McDaniel M.L. 1994. Reversibility of interleukin-1β-induced islet destruction and dysfunction by the inhibition of nitric oxide synthase. Biochem. J. 299: 719-724
23. 23. Buscema M., Vinci C., Gatta C., Rabuazzo M.A., Vignen R., Purello F. 1992. Nicotinamide partially reverses the interleukin-1β inhibition of glucose-induced insulin release in pancreatic islets. Metabolism 41: 296-300
24. 24. Andersen H.U., Jorgensen K.H., Egeberg J., Mandrup-Poulsen T., Nerup J. 1994. Nicotinamide prevents interleukin-1 effects on accumulated insulin release and nitric oxide production in rat islets of Langerhans. Diabetes 43: 770-777
25. 25. Wilson G.L., Patton N.J., McCord J.M., Mullins D.W., Mossman B.T. 1984. Mechanisms of streptozotocin-and alloxan-induced damage in rat β-cells. Diabetologia 27: 587-591
26. 26. Preiss J., Schlaeger R., Hilz H. 1971. Specific inhibition of poly ADP-ribose polymerase by thymidine and nicotinamide in HeLa cells. FEBS Lett. 19: 244-246
27. 27. Hauschildt S., Scheipers P., Bessler W.G., Mülsch A. 1992. Induction of nitric oxide synthase in L929 cells by tumor-necrosis factor α is prevented by inhibitors of poly (ADP-ribose) polymerase. Biochem. J. 288: 255-260
28. 28. Pellat-Deceunynck, Wietzerbien J., Drapier J.C. 1994. Nicotinamide inhibits nitric oxide synthase mRNA induction in activated macrophages. Biochem. J. 297: 53-58
29. 29. Fehsel K., Jalowy A., Qi S., Burkart V., Hartmann B., Kolb H. 1993. Islet cell DNA is a target of inflammatory attack by nitric oxide. Diabetes 42: 496-500
30. 30. Green I.C., Cunningham J.M., Delaney C.A., Elphick M.R., Manley J.G., Green M.H.L. 1994. Effects of cytokines and nitric oxide donors on insulin secretion, cyclic GMP and DNA damage: relation to nitric oxide production. Biochem. Soc. Transactions 22: 30-36
31. 31. Delaney C.A., Green M.H.L., Lowe J.E., Green I.C. 1993. Endogenous nitric oxide induced by interleukin-1β in rat islets of Langerhans and HIT-T15 cells causes significant DNA damage as measured by the 'comet' assay. FEBS Lett. 333: 291-295
32. 32. Kaneto H., Fujii J., Seo H.G., Suzuki K., Matsuoka T., Nakamura M., Tatsumi H., Yamasaki Y., Kamada T., Taniguchi N. 1995. Apoptotic cell death triggered by nitric oxide in pancreatic β-cells. Diabetes 44: 733-738
33. 33. Dunger A., Schlosser M., Ziegler B., Schmidt S. 1995. Interleukin 1-beta induces apoptosis in insulin-producing cells. Diabetologia 38: A38
34. 34. Ankarcrona M., Dypbukt J.M., Brüne B., Nicotera P. 1994. Interleukin-1β-induced nitric oxide production activates apoptosis in pancreatic RINm5F cells. Exp. Cell Res. 213: 172-177